Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 120 Total
NCPL - Netcapital Inc - Stock Price Chart
TickerNCPL [NASD]
CompanyNetcapital Inc
CountryUSA
IndustryCapital Markets
Market Cap1.26MEPS (ttm)-24.16
P/E-EPS this Y-485.37%
Forward P/E0.29EPS next Y103.33%
PEG-EPS past 5Y-
P/S0.35EPS next 5Y-
P/B0.03EPS Q/Q-10.76%
Dividend-Sales Q/Q-90.64%
Insider Own6.04%Inst Own3.24%
Insider Trans-Inst Trans-
Short Float0.61%EarningsSep 16/a
Analyst Recom1.00Target Price840.00
Avg Volume192.11K52W Range1.54 - 47.59
Netcapital, Inc. is a fintech company, which engages in the provision of financial solutions. The firm's platform allows private companies to raise capital online and provides private equity investment opportunities to investors. The company was founded by Sean F. Lee on April 25, 1984 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Geary Steven FDirectorApr 24 '24Buy0.13239,27431,680249,574Apr 25 08:44 PM
BSLK - Bolt Projects Holdings Inc. - Stock Price Chart
TickerBSLK [NASD]
CompanyBolt Projects Holdings Inc.
CountryUSA
IndustryShell Companies
Market Cap7.47MEPS (ttm)-0.43
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q54.14%
Dividend-Sales Q/Q-
Insider Own-Inst Own6.51%
Insider Trans-Inst Trans15.18%
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume927.17K52W Range1.00 - 17.02
Bolt Projects Holdings, Inc. manufactures natural dragline spider silk fibers using synthetic biology and micro fabrication. The company is headquartered in Kent, DE.
POAI - Predictive Oncology Inc - Stock Price Chart
TickerPOAI [NASD]
CompanyPredictive Oncology Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap5.44MEPS (ttm)-3.36
P/E-EPS this Y41.67%
Forward P/E-EPS next Y92.12%
PEG-EPS past 5Y53.33%
P/S3.11EPS next 5Y-
P/B1.14EPS Q/Q30.53%
Dividend-Sales Q/Q-43.13%
Insider Own2.27%Inst Own4.33%
Insider Trans0.00%Inst Trans-10.60%
Short Float1.20%EarningsAug 14/b
Analyst Recom1.00Target Price3.00
Avg Volume2.74M52W Range0.85 - 4.09
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate. The Helomics segment includes contract services that include the application of AI, partnering projects, and clinical testing. The zPREDICTA segment specializes in organ-specific disease models that provide 3D reconstruction of human tissues accurately representing each disease state and mimicking drug response enabling accurate testing of anticancer agents. The Skyline segment is composed of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within the Corporate segment. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nuzum Charles Lee SrDirectorSep 25 '23Sale3.0410,00030,38724,033Sep 27 05:03 PM
AEON - AEON Biopharma Inc. - Stock Price Chart
TickerAEON [AMEX]
CompanyAEON Biopharma Inc.
CountryUSA
IndustryBiotechnology
Market Cap27.23MEPS (ttm)0.52
P/E1.32EPS this Y242.86%
Forward P/E-EPS next Y-195.83%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q1054.13%
Dividend-Sales Q/Q-
Insider Own75.92%Inst Own14.55%
Insider Trans0.00%Inst Trans4.28%
Short Float1.33%EarningsAug 12/a
Analyst Recom1.00Target Price5.00
Avg Volume1.71M52W Range0.67 - 17.17
AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Oleg GrodnenskyAffiliateJul 29 '24Proposed Sale2.63201,825530,780Jul 29 04:11 PM
BLUE - Bluebird bio Inc - Stock Price Chart
TickerBLUE [NASD, RUT]
CompanyBluebird bio Inc
CountryUSA
IndustryBiotechnology
Market Cap91.18MEPS (ttm)-2.39
P/E-EPS this Y12.84%
Forward P/E-EPS next Y44.53%
PEG-EPS past 5Y28.98%
P/S2.00EPS next 5Y45.80%
P/B0.69EPS Q/Q-275.78%
Dividend-Sales Q/Q680.05%
Insider Own0.44%Inst Own42.39%
Insider Trans-0.45%Inst Trans7.50%
Short Float25.57%EarningsAug 14/b
Analyst Recom2.80Target Price3.14
Avg Volume7.34M52W Range0.48 - 5.53
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Klima Thomas JSee RemarksJun 03 '24Sale0.973,8343,726121,006Jun 04 04:22 PM
Colvin Richard AChief Medical OfficerMar 01 '24Sale1.536,77010,342118,368Mar 05 05:40 PM
Obenshain AndrewPresident and CEOMar 04 '24Sale1.536,0959,311279,998Mar 05 05:40 PM
Klima Thomas JSee RemarksMar 04 '24Sale1.534,5736,986124,840Mar 05 05:39 PM
Klima Thomas JSee RemarksFeb 05 '24Sale0.902,7142,449129,413Feb 06 04:07 PM
ACTU - Actuate Therapeutics Inc. - Stock Price Chart
TickerACTU [NASD]
CompanyActuate Therapeutics Inc.
CountryUSA
IndustryBiotechnology
Market Cap139.69MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own71.46%Inst Own-
Insider Trans11.48%Inst Trans-
Short Float0.14%Earnings-
Analyst Recom-Target Price-
Avg Volume40.07K52W Range7.33 - 10.16
Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
THOMSON TODD S16.4% OwnerAug 14 '24Sale8.0018,750150,0001,184,795Aug 16 09:12 PM
Bios Equity COF, LPDirectorAug 14 '24Buy8.00500,0004,000,0001,259,427Aug 14 08:54 PM
Bios Equity COF, LPDirectorAug 14 '24Sale9.0024,999224,991131,248Aug 14 08:54 PM
Fletcher Aaron G.L.DirectorAug 14 '24Buy8.00500,0004,000,0001,259,427Aug 14 08:49 PM
Fletcher Aaron G.L.DirectorAug 14 '24Sale9.0024,999224,991131,248Aug 14 08:49 PM
STEM - Stem Inc - Stock Price Chart
TickerSTEM [NYSE, RUT]
CompanyStem Inc
CountryUSA
IndustryUtilities - Renewable
Market Cap57.73MEPS (ttm)-4.78
P/E-EPS this Y-286.03%
Forward P/E-EPS next Y85.29%
PEG-EPS past 5Y-438.13%
P/S0.16EPS next 5Y-
P/B-EPS Q/Q-1298.25%
Dividend-Sales Q/Q-63.42%
Insider Own6.91%Inst Own51.02%
Insider Trans-3.11%Inst Trans2.02%
Short Float21.00%EarningsAug 06/a
Analyst Recom2.54Target Price2.21
Avg Volume6.34M52W Range0.37 - 5.15
Sep-16-24 07:00AM Stem Announces CEO Transition (Business Wire)
Sep-07-24 04:20AM 10 Best Green Energy Penny Stocks to Buy Now (Insider Monkey)
Aug-30-24 04:15PM Stem, Inc. Receives Continued Listing Standard Notice from NYSE (Business Wire) -5.51% -16.53%
Aug-06-24 04:15PM Stem Announces Leadership Changes (Business Wire) -40.81%
04:05PM Stem Announces Second Quarter 2024 Results (Business Wire)
Jul-25-24 08:30AM Stem Announces Second Quarter 2024 Earnings Results Conference Call (Business Wire)
Jul-15-24 03:37PM 3 Moonshot Stocks That Could Turn $5,000 Into $25,000 (InvestorPlace)
07:10AM 7 Terrible Tech Stocks to Avoid at All Costs (InvestorPlace)
Jun-29-24 08:00AM 3 Tech Stock Standouts That Could Secure Your Financial Future (InvestorPlace)
Jun-27-24 12:35PM 3 Little-Known AI Stocks That Could One Day Rival Nvidia (InvestorPlace)
Stem, Inc. engages in the provision of an energy storage system, hardware, ongoing software platform and professional services, and solar asset performance monitoring and control. The company was founded in 2009 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Russo AlanFormer CROAug 21 '24Proposed Sale0.6379,59450,500Aug 21 01:05 PM
Russo AlanFormer CROAug 16 '24Proposed Sale0.5830,00017,401Aug 21 09:37 AM
Birns Ira MDirectorJun 07 '24Option Exercise0.0024,184024,184Jun 10 04:14 PM
MORGAN MICHAEL CDirectorJun 07 '24Option Exercise0.0023,489043,987Jun 10 04:14 PM
BUZBY DAVID SDirectorJun 07 '24Option Exercise0.0023,4890119,789Jun 10 04:14 PM
CUE - Cue Biopharma Inc - Stock Price Chart
TickerCUE [NASD]
CompanyCue Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap25.49MEPS (ttm)-0.97
P/E-EPS this Y35.14%
Forward P/E-EPS next Y18.40%
PEG-EPS past 5Y10.55%
P/S3.07EPS next 5Y-
P/B1.18EPS Q/Q31.12%
Dividend-Sales Q/Q92.33%
Insider Own0.92%Inst Own30.43%
Insider Trans0.00%Inst Trans-6.78%
Short Float7.11%EarningsAug 19/a
Analyst Recom1.00Target Price3.75
Avg Volume435.74K52W Range0.54 - 3.25
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.
HBIO - Harvard Bioscience Inc. - Stock Price Chart
TickerHBIO [NASD, RUT]
CompanyHarvard Bioscience Inc.
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap119.93MEPS (ttm)-0.25
P/E-EPS this Y-46.43%
Forward P/E18.33EPS next Y100.00%
PEG-EPS past 5Y6.80%
P/S1.19EPS next 5Y10.00%
P/B1.78EPS Q/Q-191.34%
Dividend-Sales Q/Q-19.69%
Insider Own8.35%Inst Own73.10%
Insider Trans0.83%Inst Trans-2.30%
Short Float1.07%EarningsAug 08/b
Analyst Recom1.00Target Price6.25
Avg Volume129.26K52W Range2.61 - 5.56
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green James WChief Executive OfficerJun 13 '24Buy2.9110,00029,1003,111,091Jun 14 04:02 PM
Green James WChief Executive OfficerJun 06 '24Buy3.0720,00061,4003,101,091Jun 07 04:02 PM
VS - Versus Systems Inc - Stock Price Chart
TickerVS [NASD]
CompanyVersus Systems Inc
CountryCanada
IndustrySoftware - Application
Market Cap12.74MEPS (ttm)-4.49
P/E-EPS this Y79.68%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-1.01%
P/S115.86EPS next 5Y-
P/B0.31EPS Q/Q-181.27%
Dividend-Sales Q/Q-51.94%
Insider Own38.93%Inst Own0.03%
Insider Trans0.00%Inst Trans-1.15%
Short Float1.18%EarningsAug 12
Analyst Recom3.00Target Price1.99
Avg Volume1.18M52W Range1.20 - 20.80
Versus Systems, Inc. engages in the development of business-to-business video game support software. Its software platform allows video game publishers and developers to offer prize based matches. Its geographical segments include Canada and USA. The company's platform facilitates several types of single player prize challenges that includes a range of prize types, including coupons, sweepstakes style prizes, consumer packaged goods and downloadable content. The company was founded by Matthew Pierce on December 1, 1988 and is headquartered in Vancouver, Canada.
123456789101112